NORDIC SEMICONDUC And ADC SIIC On The List Of Winners And Losers Of Wednesday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are NORDIC SEMICONDUC, CARASENT, and VIVORYON. Financial Asset Price Change Updated (EST) NORDIC SEMICONDUC (NOD.OL) 119.50 34.66% 2024-04-24 12:41:29 CARASENT (CARA.OL) 14.10 28.18% 2024-04-24 12:25:24 VIVORYON…

Read More

VIVORYON Stock Impressive Rise On Wednesday, Outperforms Market

(VIANEWS) – The Market ended the session with VIVORYON (VVY.AS) jumping 26.39% to €0.91 on Wednesday while AEX-Index slid 0.09% to €874.02. About VIVORYON Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta….

Read More

MELEXIS Stock 19.69% Up On Wednesday

(VIANEWS) – The Market ended the session with MELEXIS (MELE.BR) jumping 19.69% to €84.50 on Wednesday while BEL 20 slid 0.18% to €3,883.83. MELEXIS’s last close was €70.60, 31.46% below its 52-week high of €103.00. About MELEXIS Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe,…

Read More

VIVORYON And BELUGA On The List Of Winners And Losers Of Tuesday’s Euronext Session

(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are VIVORYON, ELLIPTIC LABORATOR, and ATEME. Financial Asset Price Change Updated (EST) VIVORYON (VVY.AS) 0.79 38.33% 2024-04-23 12:04:22 ELLIPTIC LABORATOR (ELABS.OL) 16.24 8.85% 2024-04-23 12:25:55 ATEME…

Read More

VIVORYON Stock Was Up By 12.5% Today

(VIANEWS) – The Market ended the session with VIVORYON (VVY.AS) rising 12.5% to €0.51 on Monday while AEX-Index jumped 0.76% to €866.51. About VIVORYON Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta….

Read More